These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1020261)

  • 1. [Antineoplastic effect of cis-platinum diamminodichloride (II)].
    Nikolin VP; Gruntenko EV; Mal'chikov GD; Sysoeva GM
    Vopr Onkol; 1976; 22(12):73-5. PubMed ID: 1020261
    [No Abstract]   [Full Text] [Related]  

  • 2. Purification and characterization of mercenene. I. Ammonium sulfate fractionation and its effect on the growth of Krebs-2 carcinoma.
    Kolman S; Espenshade L; Zahorian G; Carr M; Nicholas A; Lin YC
    J Am Osteopath Assoc; 1972 Oct; 72(2):182-4. PubMed ID: 4484632
    [No Abstract]   [Full Text] [Related]  

  • 3. Antitumor effects of three platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum (II) monohydrate (DWA2114R), cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) (CBDCA) and cis-diamminedichloroplatinum(II) (CDDP), in mice.
    Endo K; Akamatsu K; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K
    Anticancer Res; 1992; 12(1):49-58. PubMed ID: 1567181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo antineoplastic activity of a new platinum antineoplastic agent, (R)-(-)-1,1-cyclobutanedicarboxylate (2-aminomethylpyrrolidine)-platinum (II) (DWA2114R) on freshly separated human tumor cells and human tumor xenografts transplanted in nude mice--a comparison with cis-diammine-dichloroplatinum (CDDP).
    Nio Y; Imai S; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Tobe T
    Anticancer Res; 1991; 11(2):761-7. PubMed ID: 2064331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo interaction of cis-platinum and fosfomycin on squamous cell carcinoma.
    Tandy JR; Tandy RD; Farris P; Truelson JM
    Laryngoscope; 2000 Jul; 110(7):1222-4. PubMed ID: 10892700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug resistance induction and cross-resistance studies with Pt-complexes.
    Hrubisko M; Balázová E; Ujházy V
    Neoplasma; 1984; 31(6):649-53. PubMed ID: 6542968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of cis-platinum (II) diamminodichloride on bone marrow.
    Zák M; Drobník J; Rezný Z
    Cancer Res; 1972 Mar; 32(3):595-9. PubMed ID: 5061310
    [No Abstract]   [Full Text] [Related]  

  • 8. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antitumor effectiveness and nephrotoxicity of oxoplatinum].
    Aref'eva AK; Rykov VA; Mitrokhina LN
    Vopr Onkol; 1990; 36(3):331-4. PubMed ID: 2109913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cisplatin (platidiam) and the prospects for using complex platinum compounds in the clinical chemotherapy of malignant tumors].
    Gorbunova VA
    Vopr Onkol; 1989; 35(3):325-30. PubMed ID: 2705315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA synthesis, protein synthesis and platinum content following drug administration in cis-diamminedichloroplatinum(II) -sensitive and -resistant L1210 cells transferred from in vitro to in vivo conditions.
    Hanusovská E; Ujházy V
    Neoplasma; 1987; 34(6):721-6. PubMed ID: 3431611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical evaluation of diethoxy-(1-phenyl-1,3-butanedionato) titanium (IV) in human tumour xenografts.
    Mattern J; Keppler B; Volm M
    Arzneimittelforschung; 1984; 34(10):1289-90. PubMed ID: 6549134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vivo antitumor activity of hydrosoluble derivatives of 7-hydroxycholesterols].
    Rong S; Bergmann C; Luu B; Beck JP; Ourisson G
    C R Acad Sci III; 1985; 300(3):89-94. PubMed ID: 3919887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diamminodichloride platinum (cis-platinum) in the treatment of hepatocellular carcinoma.
    Melia WM; Westaby D; Williams R
    Clin Oncol; 1981 Dec; 7(4):275-80. PubMed ID: 6172230
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II clinical trial of cis-dichlorodiammineplatinum in gastric cancer.
    Lacave AJ; Izarzugaza I; Antón Aparicio LM; Valle Pereda M; Gracia Marco JM; Buesa JM
    Am J Clin Oncol; 1983 Feb; 6(1):35-8. PubMed ID: 6682284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of treatment schedule on antitumor activity of glycolate-0,0'-diammineplatinum(II), a new platinum derivative: comparison with cis-diamminedichloroplatinum(II).
    Suzumura Y; Kato T; Ueda R; Ota K
    Anticancer Res; 1989; 9(4):1083-8. PubMed ID: 2817790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of cisplatin sensitivity of quiescent cells in solid tumors by combined treatment with tirapazamine and low-temperature hyperthermia.
    Masunaga S; Ono K; Hori H; Akaboshi M; Kawai K; Suzuki M; Kinashi Y; Kasai S; Nagasawa H; Uto Y
    Radiat Med; 1998; 16(6):441-8. PubMed ID: 9929144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Platinum complexes as radiosensitizers in radiotherapy].
    López Zúmel MC; Alvarez MV; Santos Peinado L
    Rev Esp Oncol; 1984; 31(2):227-36. PubMed ID: 6100707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of nude mouse-grown human urothelial cancer to cis-diamminedichloroplatinum(II), diammine[1,1-cyclobutanedicarboxylato(2-)-O,O'-platinum], and mitoguazone dihydrochloride.
    Kyriazis AP; Yagoda A; Kyriazis AA; Fogh J
    Cancer Res; 1985 May; 45(5):2012-5. PubMed ID: 3886128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors.
    Dominguez MF; Macias RI; Izco-Basurko I; de La Fuente A; Pascual MJ; Criado JM; Monte MJ; Yajeya J; Marin JJ
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1106-12. PubMed ID: 11356935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.